Clinical Trial Update: Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating baclofen to prevent agitation in alcohol-addicted patients in ICU has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

Sponsor: Nantes University Hospital | Conditions: Alcoholism | Phase 3 | Status: COMPLETED